Change Control. A Key Element of a Quality System

Size: px
Start display at page:

Download "Change Control. A Key Element of a Quality System"

Transcription

1 IVT 9 th Annual Conference Change Control Change Control A Key Element of a Quality System Jerry Lanese Ph.D. CMC The Lanese Group, Inc The Lanese Group 1

2 Will discuss A Quality System What is it Purpose Quality System compared to other management systems Continuous improvement Integrated components of a Quality System 2011 The Lanese Group 2

3 What is a Quality System 2011 The Lanese Group 3

4 2011 The Lanese Group 4

5 2011 The Lanese Group 5

6 2011 The Lanese Group 6

7 2011 The Lanese Group 7

8 Management Review Change Control records Investigations Documents Production Controls Validation 2011 The Lanese Group 8

9 2011 The Lanese Group 9

10 ` 2011 The Lanese Group 10

11 Organizational Profile: Environment, Relationships, and Challenges Strategic Planning Human Resource Focus Leadership Business Results Customer and Market Focus Process Management 2011 The Lanese Group Measurement, Analysis and Knowledge Management 11 Baldrige

12 Baldrige Organizational Profile 1. Leadership 2. Strategic Planning 3. Customer and Market Focus 4. Measurement, Analysis, and Knowledge Management 5. Human Resource Focus 6. Process Management 7. Business Results

13 Continual Improvement of the quality management system Management Responsibility Customers Customers Resource Management Measurement, Analysis and Improvement Requirements Input Product Realization QMS Output Product Satisfaction ISO

14 Management Design Controls Production & Process Controls Material Controls Corrective & Preventive Actions Records, Documents, & Change Controls Equipment & Facility Controls Controls 2011 The Lanese Group 14 FDA QSIT Presentation

15 Medical Device Reporting Reports of Corrections and Removals Medical Device Tracking Facility & Equipment Controls Corrective & Preventive Actions Design Controls MANAGEMENT 2011 The Lanese Group Material Controls Records/ Documents/ Change Controls 15 Production & Process Controls Sterilization Process Controls FDA QSIT Presentation

16 Production System Quality Packaging & Labeling System Facilities & Equipment System System Materials System Laboratory Controls System

17 Purpose of a XXX Quality System To enhance the quality and availability of products around the world in the interest of public health. Facilitate innovation and continual improvement and strengthen the link between development and manufacturing activities The Lanese Group 17

18 What is in the Quality System 2011 The Lanese Group 18

19 Process Performance and Product Quality Monitoring Corrective Action Preventive Action Change Management Management Review of Process Performance and Product Quality Elements that promote the life-cycle approach ICH Q7A Regional EU GMP GMPs 21CFR 210, 21CFR211 Regional GMPs 2011 The Lanese Group 19

20 Process Performance and Product Quality Monitoring Corrective Action Preventive Action Change Management Management Review of Process Performance and Product Quality ICH Q7A EU GMP 21CFR 210, 21CFR211 Regional GMPs 2011 The Lanese Group 20

21 Process Performance and Product Quality Monitoring Corrective Action Preventive Action Change Management Management Review of Process Performance and Product Quality ICH Q7A EU GMP 21CFR 210, 21CFR211 Regional GMPs 2011 The Lanese Group Product Realization ICH Q10 State of Control Objectives Continual Improvement 21

22 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 22 ICH Q10 4 June 2008

23 Product Lifecycle Corporate Support and Management Operations Develop Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 23

24 Product Lifecycle Corporate Support and Management Operations Develop GMPs Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 24

25 Product Lifecycle Corporate Support and Management Operations Develop Six Commercialize Systems Discovery Transfer Discontinuation 2011 The Lanese Group 25

26 Product Lifecycle Corporate Support and Management Operations Develop Baldrige Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 26

27 Product Lifecycle Corporate Support and Management Operations Develop ICH Q10 Commercialize Discovery Transfer Discontinuation 2011 The Lanese Group 27

28 Development Change management 2011 The Lanese Group 28

29 Change Change Management 2011 The Lanese Group 29

30 Requirement for change control These written procedures, including any changes, shall be drafted, reviewed, and approved by the appropriate organizational units and reviewed and approved by the quality control unit. 21CFR (a) 2011 The Lanese Group 30

31 Requirement for change control The establishment of any specifications, standards, sampling plans, test procedures, or other laboratory control mechanisms required by this subpart, including any change in such specifications, standards, sampling plans, test procedures, or other laboratory control mechanisms, shall be drafted by the appropriate organizational unit and reviewed and approved by the quality control unit The Lanese Group 31 21CFR (a)

32 Requirement for change control Document changes. Changes to documents shall be reviewed and approved by an individual(s) in the same function or organization that performed the original review and approval, unless specifically designated otherwise. 21CFR820.40(b) 2011 The Lanese Group 32

33 Requirement for change control Approved changes shall be communicated to the appropriate personnel in a timely manner. Each manufacturer shall maintain records of changes to documents. 21CFR820.40(b) 2011 The Lanese Group 33

34 Requirement for change control Change records shall include a description of the change, identification of the affected documents, the signature of the approving individual(s), the approval date, and when the change becomes effective. 21CFR820.40(b) 2011 The Lanese Group 34

35 Requirement for change control Production and process changes. Each manufacturer shall establish and maintain procedures for changes to a specification, method, process, or procedure. Such changes shall be verified or where appropriate validated according to , before implementation and these activities shall be documented. Changes shall be approved in accordance with The Lanese Group 35 21CFR820.70(b)

36 Change Control A formal change control system should be established to evaluate all changes that could affect the production and control of the intermediate or API. ICH Q7; The Lanese Group 36

37 Change Control Written procedures should provide for the identification, documentation, appropriate review, and approval of changes in raw materials, specifications, analytical methods, facilities, support systems, equipment (including computer hardware), processing steps, labeling and packaging materials, and computer software. ICH Q7; The Lanese Group 37

38 Change Control Any proposals for GMP relevant changes should be drafted, reviewed, and approved by the appropriate organizational units and reviewed and approved by the quality unit(s). ICH Q7; The Lanese Group 38

39 Change Control The potential impact of the proposed change on the quality of the intermediate or API should be evaluated. A classification procedure may help in determining the level of testing, validation, and documentation needed to justify changes to a validated process. ICH Q7; The Lanese Group 39

40 Change Control Changes can be classified (e.g., as minor or major) depending on the nature and extent of the changes, and the effects these changes may impart on the process. Scientific judgment should determine what additional testing and validation studies are appropriate to justify a change in a validated process The Lanese Group 40 ICH Q7; 13

41 Change Control When implementing approved changes, measures should be taken to ensure that all documents affected by the changes are revised. After the change has been implemented, there should be an evaluation of the first batches produced or tested under the change The Lanese Group 41 ICH Q7; 13

42 Change Control (definition) A formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might affect the validated status of facilities, systems, equipment or processes. The intent is to determine the need for action that would ensure and document that the system is maintained in a validated state The Lanese Group 42 EU GMP; Annex 15

43 Change Control (definition) A formal system in which proposed changes are evaluated and monitored to assure that they result in products of equal or improved quality, process of equal or improved efficiency and compliance while maintaining appropriate regulatory submissions. Lanese 2011 The Lanese Group 43

44 Responsibilities of the Change Control Program Review all changes proposed for the GMP facilities, equipment, materials, processes to determine if there is a potential impact on product quality 2011 The Lanese Group 44

45 Responsibilities of the Change Control Program If there is potential impact: Inform all appropriate units of the potential impact. Coordinate appropriate regulatory submissions. Assure that the proposed change is completed in a timely manner and required changes to documentation and other supporting systems are made. Verify that the change achieves its intended purpose The Lanese Group 45

46 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 46 ICH Q10 4 June 2008

47 Main objectives of a Quality System Achieve product realization Establish and maintain a state of control Facilitate continual improvement ICH Q The Lanese Group 47

48 P plan A act D do C check

49 Requirements Inputs Overview of a Modern Pharmaceutical Quality System Continual Improvement Act Management Resources Manufacturing Evaluation Plan Do Check Quality System Infrastructure Quality by Design Risk Management Chris Joneckis, PhD, FDA

50 Continual Improvement of the quality management system Management Responsibility Customers Customers Resource Management Measurement, Analysis and Improvement Requirements Input Product Realization QMS Output Product Satisfaction ISO

51 PDCA Plan: Put in place all of supporting system changes to support the overall change Do: Implement the changed process. Check: Verify - Monitor and measure the processes and product against established performance measures Act: Recommend the next change to continually improve process performance

52 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 52 ICH Q10 4 June 2008

53 Corrective action/preventive action Development Not applicable, CAPA incorporated into interactive design process Technology transfer Provides feedback on the effectivity of the development process Manufacturing A formal quality system, adds to knowledge database Product Discontinuance Investigations evaluate impact on remaining product and other products 2011 The Lanese Group 53

54 Change Management Development Documents all changes - increases formality of the process as product matures Technology transfer Key knowledge transfer tool Manufacturing Formal system must be in place Product Discontinuance Records maintained and destroyed after retention period 2011 The Lanese Group 54

55 Product Reviews Validate Verify Inspectional Observations Development Change Audit Observations CAPA Deviations Product Monitoring Investigations 2011 The Lanese Group 55

56 Change Management System Change Control System Senior Management 2011 The Lanese Group 56

57 Recommend Change 2011 The Lanese Group 57

58 Product Reviews Validate Verify Inspectional Observations Development Change Audit Observations CAPA Deviations Product Monitoring Investigations 2011 The Lanese Group 58

59 Recommend Change Log into project management system Prepare forms required by CM program Estimate costs 2011 The Lanese Group 59

60 Require Mgmt Approval No No Yes Require Change Control Yes Management approves funding 2011 The Lanese Group 60

61 Manage Change Project Implement Change Initiate CC Forms Define CC requirements, communicate Monitor Change Project 2011 The Lanese Group 61

62 CC Project Yes Perform Verification Tests Evaluate Verification Date 2011 The Lanese Group 62

63 Close out project Meet Criteria Yes Close out Change Control Documents 2011 The Lanese Group 63

64 ICH Q10 Pharmaceutical Quality System Pharmaceutical Development Technology Transfer Commercial Manufacturing Product Discontinuance Investigational Products GMP Management Responsibilities PQS Elements Process Performance and Product Quality Monitoring System Corrective Action/Preventive Action (CAPA) System Change Management System Management Review Enablers 2011 The Lanese Group Knowledge Management Quality Risk Management 64 ICH Q10 4 June 2008

65 2011 The Lanese Group 65

66 Develop a Quality System that fits the business and compliance needs 2011 The Lanese Group 66

67 Contact Information Jerry Lanese Ph.D. The Lanese Group, Inc Catalina Leawood, KS The Lanese Group 67

68 IVT 9 th Annual Conference Change Control Change Control A Key Element of a Quality System Jerry Lanese Ph.D. CMC The Lanese Group, Inc The Lanese Group 68

Industry Implications of Pharmaceutical Quality ICH Guidelines

Industry Implications of Pharmaceutical Quality ICH Guidelines EIPG General Assembly Industry Implications of Pharmaceutical Quality ICH Guidelines 20 th April 2008 Pharmaceutical Quality Develop a harmonised pharmaceutical quality system applicable across the lifecycle

More information

ICH guideline Q10 on pharmaceutical quality system

ICH guideline Q10 on pharmaceutical quality system September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final

More information

Guidance for Industry. Q10 Pharmaceutical Quality System

Guidance for Industry. Q10 Pharmaceutical Quality System Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management

More information

Pharmaceutical Quality Management System: Current Concept

Pharmaceutical Quality Management System: Current Concept Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute

More information

PHARMACEUTICAL QUALITY SYSTEM Q10

PHARMACEUTICAL QUALITY SYSTEM Q10 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step

More information

ICH Q10 Pharmaceutical Quality System (PQS)

ICH Q10 Pharmaceutical Quality System (PQS) ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives

More information

ICH Q10 - Pharmaceutical Quality System

ICH Q10 - Pharmaceutical Quality System WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,

More information

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal

More information

Corrective and Preventive Actions

Corrective and Preventive Actions Corrective and Preventive Actions A Five Step Approach Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap What

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

Best Practice In A Change Management System

Best Practice In A Change Management System Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits

More information

ISO 13485:201x What is in the new standard?

ISO 13485:201x What is in the new standard? ISO 13485:201x What is in the new standard? Eric Finegan, Quality Mgr, BTE Technologies, Inc. 2015-09-10 1 Presentation Slides This slide deck is the presentation performed on 2015-09-10. A more detailed

More information

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected]

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected] Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process

More information

Harmonizing Change Control Processes Globally

Harmonizing Change Control Processes Globally Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses

More information

The Effective Management of Change Across the ICHQ10 Lifecycle

The Effective Management of Change Across the ICHQ10 Lifecycle The Effective Management of Change Across the ICHQ10 Lifecycle Rob Hughes AstraZeneca 1 Change Management the guide This presentation will: describe a structured approach to change across the ICH Q10 lifecycle

More information

White paper: How to implement a Quality Management System

White paper: How to implement a Quality Management System White paper: How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

ICH Public Meeting. Joseph C. Famulare. October 2, 2006. Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance

ICH Public Meeting. Joseph C. Famulare. October 2, 2006. Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance ICH Public Meeting October 2, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance The Current State of Pharmaceutical Manufacturing Inability to predict

More information

State of Control Over the Lifecycle and Process Validation (New and Legacy Products)

State of Control Over the Lifecycle and Process Validation (New and Legacy Products) State of Control Over the Lifecycle and Process Validation (New and Legacy Products) Grace McNally Branch Chief (acting), Regulatory Policy and Collaboration Branch FDA/CDER/Office of Compliance ICH Q10,

More information

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) Nutrition Supplier Meeting, June 30, 2015 Dimitris Catsoulacos Quality Assurance Specialist PRESENTATION OVERVIEW Quality

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

Introduction to Q10 Pharmaceutical Quality System

Introduction to Q10 Pharmaceutical Quality System ICH-GCG Asean Training Workshop on ICH Guidelines Q8,Q9 and Q10 (New Paradigm) Introduction to Q10 Pharmaceutical Quality System Georges FRANCE, Q- IWG Kuala Lumpur, Malaysia 26-28 July 2010 International

More information

How to implement a Quality Management System

How to implement a Quality Management System How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your

More information

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Quality Systems: US Perspective Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical

More information

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction

More information

Audit Report in the framework of the APIC Audit Programme

Audit Report in the framework of the APIC Audit Programme Audit Report in the framework of the APIC Audit Programme Company Location Address Country Subject of Audit Audit Date Auditor (lead) Co-Auditor(s) Participants Signature of Auditor(s) Lead Auditor Co-Auditor

More information

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 December 2010 EMA/CHMP/ICH/265145/ Committee for medicinal products for human use (CHMP) ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 Step 5 Transmission to CHMP for information December

More information

Guidance for Industry: Quality Risk Management

Guidance for Industry: Quality Risk Management Guidance for Industry: Quality Risk Management Version 1.0 Drug Office Department of Health Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. What is risk?... 4 5. Integrating

More information

ISO 9001 : 2008 QUALITY MANAGEMENT SYSTEM AUDIT CHECK LIST INTRODUCTION

ISO 9001 : 2008 QUALITY MANAGEMENT SYSTEM AUDIT CHECK LIST INTRODUCTION INTRODUCTION What auditors should look for: the items listed in these headings that the ISO requirement is met that the requirement is met in the manner described in the organization's documentation Page

More information

ORACLE CONSULTING GROUP

ORACLE CONSULTING GROUP ORACLE CONSULTING GROUP 9 Golder Ranch Rd., Ste. 1 Tucson, Arizona 9 Web Site: E-mail: 20-2-0 20-2-0 (FAX) CONSULTING MEMORANDUM QUALITY SYSTEM INSPECTION TECHNIQUE

More information

Lifecycle CMC Management: ICH Q12 Progress to date

Lifecycle CMC Management: ICH Q12 Progress to date Lifecycle CMC Management: ICH Q12 Progress to date BWP/QWP/GMDP IWG Industry European workshop 28-29 October 2015 Jean-Louis ROBERT (EU) Graham Cook (EFPIA) Please take note The following slides represent

More information

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

Comparison between FDA QSR and ISO 13485

Comparison between FDA QSR and ISO 13485 Comparison between FDA QSR and ISO 13485 Most countries in the world including the Europe, for the conformity assessment of medical devices to be used by their countrymen, assess not only whether the product

More information

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes

More information

ISO-9001:2000 Quality Management Systems

ISO-9001:2000 Quality Management Systems ISO-9001:2000 Quality Management Systems REQUIREMENTS 10/10/2003 ISO-9001:2000 Requirements 1 Process Based Approach C U S MANAGEMENT RESPONSIBILITY RESOURCE MANAGEMENT C U S T O M Requirements PRODUCT

More information

White paper: FDA Guidance for Industry Update Process Validation

White paper: FDA Guidance for Industry Update Process Validation White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,

More information

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

Testing Automated Manufacturing Processes

Testing Automated Manufacturing Processes Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls

More information

Implementing New USP Chapters for Analytical Method Validation

Implementing New USP Chapters for Analytical Method Validation Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: [email protected] Today s Agenda Handling Method Changes vs. Adjustments

More information

FDA Guidance for Industry Update - Process Validation

FDA Guidance for Industry Update - Process Validation FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead

More information

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle Process Performance Qualification Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle A LIFECYCLE Approach to Process Validation? Lifecycle [ICH Q8(R2)]: All phases

More information

What is Process Validation?

What is Process Validation? What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process

More information

Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.

Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37. Job description Job title Directorate Pay band Responsible to Base/location Process Engineer Production SEO Process Engineering Manager Porton Hours/sessions per week 37.5 Job type Permanent INTRODUCTION

More information

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations

Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

QSIT Management Controls. QSIT Workshops

QSIT Management Controls. QSIT Workshops QSIT Management Controls QSIT Workshops Management Controls Importance Assessment Demonstration of Compliance Quality System Design Controls Material Controls Corrective & Preventive Actions Management

More information

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014 Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing

More information

QW Enterprises, LLP. Quality Manual

QW Enterprises, LLP. Quality Manual QW Enterprises, LLP Quality Manual ISO 9001:2008 Quality Manual 9001 2008 D1 Quality Manual 9001 2008 D1 Page 2 of 34 0 Table of contents 0 Table of contents 2 1 General 5 1.1 Purpose and scope 5 1.2 Application

More information

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Quality Risk Management 11 November 2011 Galway, Ireland Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Overview Regulatory

More information

Internal Quality Management System Audit Checklist (ISO9001:2015) Q# ISO 9001:2015 Clause Audit Question Audit Evidence 4 Context of the Organization

Internal Quality Management System Audit Checklist (ISO9001:2015) Q# ISO 9001:2015 Clause Audit Question Audit Evidence 4 Context of the Organization Internal Quality Management System Audit Checklist (ISO9001:2015) Q# ISO 9001:2015 Clause Audit Question Audit Evidence 4 Context of the Organization 4.1 Understanding the organization and its context

More information

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009 EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009 contact data Bernd Boedecker Staatliches Gewerbeaufsichtsamt

More information

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human

More information

ISO 9001:2000 Gap Analysis Checklist

ISO 9001:2000 Gap Analysis Checklist ISO 9001:2000 Gap Analysis Checklist Type: Assessor: ISO 9001 REQUIREMENTS STATUS ACTION/COMMENTS 4 Quality Management System 4.1 General Requirements Processes needed for the quality management system

More information

QMS - Johtaminen. Tom Ståhlberg 20.3.2013. FiHTA

QMS - Johtaminen. Tom Ståhlberg 20.3.2013. FiHTA QMS - Johtaminen Tom Ståhlberg 20.3.2013 FiHTA Management subsystem QSR and ISO 13485:2003 Responsibilities Quality Policy Resources Management representative Management Review Quality planning Quality

More information

ISO 9001 (2000) QUALITY MANAGEMENT SYSTEM ASSESSMENT REPORT SUPPLIER/ SUBCONTRACTOR

ISO 9001 (2000) QUALITY MANAGEMENT SYSTEM ASSESSMENT REPORT SUPPLIER/ SUBCONTRACTOR Page 1 of 20 ISO 9001 (2000) QUALITY MANAGEMENT SYSTEM ASSESSMENT REPORT SUPPLIER/ SUBCONTRACTOR SUPPLIER/ SUBCONTRACTOR NAME: ADDRESS: CITY AND STATE: ZIP CODE: SUPPLIER/MANUFACTURER NO PHONE: DIVISION:

More information

Full Compliance Contents

Full Compliance Contents Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex

More information

The Gap Analysis Checklist

The Gap Analysis Checklist The Gap Analysis Checklist This table outlines the changes to align your organization with the 21CFR820 requirements. The applicable parts of the regulation that result in additions for the QSR are highlighted

More information

Process Validation: Practical Aspects of the New FDA Guidance

Process Validation: Practical Aspects of the New FDA Guidance Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory

More information

Correlation matrices between 9100:2009 and 9100:2016

Correlation matrices between 9100:2009 and 9100:2016 Correlation matrices between 9100:2009 and 9100:2016 This document gives correlation matrices from 9100:2009 to 9100:2016. This document can be used to highlight where the new and revised clauses are located.

More information

Guidance for Industry: Starting Material Supplier Management

Guidance for Industry: Starting Material Supplier Management Guidance for Industry: Starting Material Supplier Management Version 1.0 Drug Office Department of Health. Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. Selecting and

More information

Supplier Quality Management System Audit Checklist (ISO 9000:2000, TS 16949:2002)

Supplier Quality Management System Audit Checklist (ISO 9000:2000, TS 16949:2002) Supplier Quality Management System Audit Checklist (ISO 9000:2000, TS 16949:2002) Supplier: Plant/Location: Date: Audit Team: Scope of Audit: Number of C.A.R. s: Corrective Action Due: Potential suppliers

More information

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Los Angeles, CA July 28th & 29th, 2016

More information

ISO 9001:2000 AUDIT CHECKLIST

ISO 9001:2000 AUDIT CHECKLIST ISO 9001:2000 AUDIT CHECKLIST No. Question Proc. Ref. Comments 4 Quality Management System 4.1 General Requirements 1 Has the organization established, documented, implemented and maintained a quality

More information

Quality Risk Management ICH Q9 & ISO 14971. Presented by Michael Kerr 11 th November 2011

Quality Risk Management ICH Q9 & ISO 14971. Presented by Michael Kerr 11 th November 2011 Quality Risk Management ICH Q9 & ISO 14971 Presented by Michael Kerr 11 th November 2011 Agenda Risk Concept QRM Fundamentals Regulatory Expectations Warning Letters / Observations Application of QRM Introduction:

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control

More information

Preparation for ISO 45001 OH&S Management Systems

Preparation for ISO 45001 OH&S Management Systems Preparation for ISO 45001 OH&S Management Systems HEALTH & SAFETY MANAGEMENT QUALITY MANAGEMENT ACCESSIBILITY ENVIRONMENTAL MANAGEMENT ENERGY MANAGEMENT ISO 45001 TIMELINE ISO project committee ISO PC

More information

QUALITY RISK MANAGEMENT (QRM): A REVIEW

QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate

More information

Pharmaceutical Auditor Training

Pharmaceutical Auditor Training www.nsf.org Formerly NSF-DBA The right people. The right solution. The first time. Pharmaceutical or Training Pharmaceutical GMP s and Self-Inspections PQMS or/lead or Training Course A17638 Why Choose

More information

ICH Q7 GMP for Active Pharmaceutical Ingredients

ICH Q7 GMP for Active Pharmaceutical Ingredients National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents ICH Q7 GMP for Active Pharmaceutical Ingredients Part of the Pharmaceutical Biotechnology Training Courses

More information

Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003. Change Control

Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003. Change Control Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003 Change Control Wolfgang Schumacher Roche Pharmaceuticals, Basel Agenda Change Control Definitions

More information

ISO 9001:2008 Requirements Explained - An Adobe PDF File for Use on a Network System

ISO 9001:2008 Requirements Explained - An Adobe PDF File for Use on a Network System 1-2 3 4 5 6 9 9 29 37 44 57 64 67 70 77 85 90 93 97 101 110 112 113 122 125 127 135 139 146 150 157 161 165 168 172 175 180 187 190 193 201 206 209 212 216 227 233 235 247 251 258 264 272 274 286 1 of

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters

How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters environmental failure analysis & prevention health technology development How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters Kevin L. Ong, Ph.D., P.E. Managing

More information

Author General Management Quality Assurance

Author General Management Quality Assurance Lab Ofichem B.V. Pag.: 1 / 14 Date: 20-01- Version: 02 Status: geldig Contents 1. General... 2 2. Shared Third Party audit program... 3 3. Reassurance absence of Conflict of Interest... 5 4. Contract structure...

More information

Rx-360 Supplier Assessment Questionnaire (SAQ)

Rx-360 Supplier Assessment Questionnaire (SAQ) Rx-360 Supplier Assessment Questionnaire (SAQ) The Rx-360 Supplier Assessment Questionnaire (SAQ) was created by the Rx-360 Supplier-Led Working Group. The Supplier-Led Working Group is an Rx-360 working

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

ISO 9001:2008 Quality Management System Requirements (Third Revision)

ISO 9001:2008 Quality Management System Requirements (Third Revision) ISO 9001:2008 Quality Management System Requirements (Third Revision) Contents Page 1 Scope 1 1.1 General. 1 1.2 Application.. 1 2 Normative references.. 1 3 Terms and definitions. 1 4 Quality management

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

Workshop on process validation

Workshop on process validation Workshop on process validation General concepts on process validation Kowid Ho Scope / background Process evaluation/validation of biotechnology derived proteins used as active substance in the manufacture

More information

QUALITY MANAGEMENT SYSTEM REVIEW AND APPROVAL TEMPLATE (DOE G 414.1-2A, Appendix A, 6-17-05)

QUALITY MANAGEMENT SYSTEM REVIEW AND APPROVAL TEMPLATE (DOE G 414.1-2A, Appendix A, 6-17-05) QUALITY MANAGEMENT SYSTEM REVIEW AND APPROVAL TEMPLATE (DOE G 414.1-2A, Appendix A, 6-17-05) This review template is intended for use by the DOE for evaluating a DOE Site Office or Contractor Quality Assurance

More information

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations This paper discusses the nuances of lifecycle validation implementation at contract manufacturing organizations (CMOs).

More information

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog. Quality Thinking in other Industries Dominic Parry Inspired Pharma Training WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.com Welcome The traditional focus on quality Quality in the eyes of GMP

More information

Intland s Medical Template

Intland s Medical Template Intland s Medical Template Traceability Browser Risk Management & FMEA Medical Wiki Supports compliance with IEC 62304, FDA Title 21 CFR Part 11, ISO 14971, IEC 60601 and more INTLAND codebeamer ALM is

More information

Risk management is one of the new requirements for. An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems

Risk management is one of the new requirements for. An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems vember 2013 Spectroscopy 28(11) 1 Focus on Quality An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems A risk assessment is presented for determining the amount

More information

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director

More information

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11 Impact Assessment in a Science & Risk Based Environment R. Legland 11/04/11 Background US GMP s EU GMP s Japan GMP s ICH Q8, Q9, Q10 Guidance ASTM Standard E2500-07 Science and Risk Based Approach to Determine

More information

Quality Manual ISO 9001:2015 Quality Management System

Quality Manual ISO 9001:2015 Quality Management System Quality management input comprises the standard requirements from ISO 9001:2015 which are deployed by our organization to achieve customer satisfaction through process control. Quality Manual ISO 9001:2015

More information

OPERATIONAL STANDARD

OPERATIONAL STANDARD 1 of 11 1. Introduction The International Safe Transit Association (ISTA), a non-profit association whose objective is to prevent product damage and excess packaging usage within the distribution environment.

More information

Medical Device Training Program 2015

Medical Device Training Program 2015 Medical Device Training Introduction Supplementary training and education is often overlooked by medical device professionals until it is triggered by an upcoming FDA or Notified Body and/or ISO 13485

More information

AS9100 Quality Manual

AS9100 Quality Manual Origination Date: August 14, 2009 Document Identifier: Quality Manual Revision Date: 8/5/2015 Revision Level: Q AS 9100 UNCONTROLLED IF PRINTED Page 1 of 17 1 Scope Advanced Companies (Advanced) has established

More information

ISO/IEC 17025 QUALITY MANUAL

ISO/IEC 17025 QUALITY MANUAL 1800 NW 169 th Pl, Beaverton, OR 97006 Revision F Date: 9/18/06 PAGE 1 OF 18 TABLE OF CONTENTS Quality Manual Section Applicable ISO/IEC 17025:2005 clause(s) Page Quality Policy 4.2.2 3 Introduction 4

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex

More information

ISO 9001:2000 - A Quality Manual for the Transition Period and Beyond

ISO 9001:2000 - A Quality Manual for the Transition Period and Beyond ISO 9001:2000 - A Quality Manual for the Transition Period and Beyond By Mark Kaganov Abstract This article shows a practical approach to converting an ISO 9001:1994 quality manual into the new ISO 9001:2000

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

2014 Annual FDA Medical Device Quality System Data. FDA Form 483 Observations and Warning Letter Citations

2014 Annual FDA Medical Device Quality System Data. FDA Form 483 Observations and Warning Letter Citations 2014 Annual FDA Medical Device Quality System Data FDA Form 483 Observations and Warning Letter Citations Why is FDA making these data available? In support of the FDA s Transparency and Case for Quality

More information